Immunogenicity assessment of monoclonal antibodies intended for in vivo clinical use

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberEMA/CHMP/BMWP/86289/2010
Effective from01/12/2012
KeywordsImmunogenicity, monoclonal antibodies, similar biological medicinal products, clinical use, assay strategy
DescriptionThis document addresses issues relating to the unwanted immunogenicity of monoclonal antibodies intended for clinical use. It is intended as an addendum to the guideline on immunogenicity assessment of biotechnology-derived therapeutic proteins.

Document history

First version

Current version

Adopted guideline

Overview of comments

Draft guideline

Concept paper

In operation: 01/12/2012–present

Published: 15/06/2012

Published: 26/11/2010

Published: 19/03/2009

Related content

How helpful is this page?

Average rating:

 Based on 21 ratings

Add your rating:

See all ratings
4 ratings
4 ratings
5 ratings
4 ratings
4 ratings

Tell us more